Clinical Trial Regulations and GCP Compliance as they relate to Adverse Events
Conduct of the Tougher U.S. FDA cGMP Inspection
Purchasing Controls and Risk Management
Handling OOS(Out-of-Specification)/OOT(Out-of-Trend)
Managing Immunogenicity Risk in Biopharmaceuticals
Update on UDI and learn how to implement the Unique Device Identification for Device
The 510(k) Process and Risk Management
How to investigate environmental monitoring excursion limits
Enter your email address:
Delivered by FeedBurner
Copyright ThisConference.com
